Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

5-alpha Avocuta active in seborrhea

Sep. 15, 2004

CollaGenex files for trademark Oracea for rosacea treatment Col-101

Sep. 15, 2004

Schering AG names new derma company Intendis

Sep. 14, 2004

Nucryst reports phase IIa results for NPI-32101 in atopic dermatitis

Sep. 10, 2004

Characterization of the antiinflammatory effects of topical tacrolimus in atopic dermatitis

Sep. 7, 2004

Clinical benefits of mepolizumab in eosinophilic skin disorders

Sep. 7, 2004

NDA submission for Aczone

Sep. 3, 2004

Good efficacy and safety profile found for XP-828L in mild to moderate psoriasis

Sep. 3, 2004

Ark signs marketing agreement with Teva for Keraboot in Israel

Sep. 1, 2004

Preliminary phase II results for XMP-629

Aug. 19, 2004